0
Skip to Content
Auransa
PLATFORM
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
ABOUT US
LEADERSHIP
PRESS
PUBLICATIONS
CONTACT
Auransa
PLATFORM
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
ABOUT US
LEADERSHIP
PRESS
PUBLICATIONS
CONTACT
PLATFORM
Folder: PIPELINE
Back
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
Folder: COMPANY
Back
ABOUT US
LEADERSHIP
Folder: MEDIA
Back
PRESS
PUBLICATIONS
CONTACT

AI-Biopharma Auransa Announces Successful First Patient Dosed in Phase 1 Clinical Trial for Liver Cancer

Sep 14
Written by Yolandi Stanek
Yolandi Stanek https://helloyo.com
Previous
Previous

Seven AI/ML for Life Sciences Companies Identified as Innovators in New Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report

Next
Next

USC Norris collaborates with Auransa on clinical trial of new targeted treatment for liver cancer and other solid tumors

© 2026 Auransa Inc. All rights reserved.

Auransa is committed to protecting and respecting your privacy. We don't collect personal data and we don't use cookies to collect personally identifiable information about visitors to this website.